ABUS

#2561
Arbutus Biopharma Corporation Common Stock
4.35 USD
-0.46%
Sektör: Sağlık Hizmetleri
Baz: USD
Kar Para Birimi: USD
Günlük Aralık
4.35
4.35
Yıllık Aralık
2.94
5.10
Günlük Değişim
-0.46%
Aylık Değişim
+1.16%
6 aylık değişim
+2.59%
Yıllık Değişim
+32.62%
Önceki Kapanış
4.37
Open
4.35
Bid
Ask
Low
4.35
High
4.35
Hacim
83
Open full chart

Financials

Overview Rapor Statistics
Quarterly Annual
  • Market Capitalization 850.33 M
  • Employee 19
  • Founded 2007
  • CEO William H. Collier
  • Website www.arbutusbio.com
  • Headquarter British Columbia, Canada
  • FIGI BBG000RR8V85
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-28.29
Price to sales ratio
65.44

Arbutus Biopharma Corporation

Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection. It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007.

Haberler